Nova Benchtop System

The United States Army Medical Research Acquisition Activity (USAMRAA), on behalf of the Walter Reed Army Institute of Research (WRAIR), has issued a Special Notice regarding a sole source procurement for a Nova Benchtop Microfluidics device. The notice, posted on December 31, 2024, with a response deadline of January 16, 2025, is associated with the Defense Health Agency and falls under the Analytical Laboratory Instrument Manufacturing NAICS category. The procurement is specifically targeting a microfluidics device from Helix Biotech, designed for mRNA encapsulation and cell delivery. The device is described as a chip-less, scalable, and highly flexible modular system for producing lipid nanoparticles. This Special Notice follows Federal Acquisition Regulation (FAR) 13.106 guidelines for sole source procurement.

The primary objective of this Special Notice is to acquire a specialized microfluidics device with comprehensive support services, including delivery, self-installation, virtual training, and a one-year manufacturer warranty. Interested contractors are invited to submit capability information in writing by 2:00 p.m. Eastern Time on January 16, 2025, to Ms. Natalie Bethel at the provided email address. Contractors must provide detailed supporting evidence demonstrating their ability to meet the specified capabilities. While the notice emphasizes this is not a competitive quotation request, the government will evaluate any received responses and retains sole discretion in determining the procurement's competition status. If no responses are received, USAMRAA will proceed with the sole source contract with Helix Biotech. The opportunity is open to contractors who can substantiate their capability to provide the required microfluidics device and associated services.